Align Technology: The Short-Sellers Are Wrong

RichLegg/E+ via Getty Images Introduction & Investment Thesis I initiated a "hold" rating on Align Technology (NASDAQ:ALGN) on March 1, where my thesis was predicated on my belief that the stock could remain under pressure as its operating margin had been declining, even though the company was showing signs of recovering revenue growth. Since then, the medical device company known for its Invisalign product has underperformed the S&P 500 (SPY) and Nasdaq 100 (QQQ) and is down 19% since the time of my writin ...